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Abstract:13
In this work, we aimed to develop new materials to reduce the secondary injuries which14
can be imparted when replacing wound dressings. Electrospun fibers based on the15
thermoresponsive polymer poly(N-isopropylacrylamide) (PNIPAAm), poly(l-lactic16
acid-co-ɛ-caprolactone) (PLCL), and the antibiotic ciprofloxacin (CIF) were prepared. 17
The water contact angle of fibers made from a blend of PNIPAAm and PLCL changed18
dramatically when the temperature was increased above 32 °C. Sustained release of19
CIF from the formulations was observed over more than 200 h. Moreover, L92920
fibroblasts could proliferate on the fibers, indicating their biocompatibility. The CIF-21
loaded fibers were found to have potent antibacterial activity against E. coli and S.22
Aureus. In vivo tests on rats indicated that CIF-loaded thermosensitive fibers have23
enhanced healing performance compared to CIF loaded PLCL fibers or a commercial24
gauze. Electrospun PNIPAAm/PLCL fibers loaded with CIF thus have great promise in25
the development of new wound dressing materials.26
27
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21. Introduction:1
Wound healing is a complicated biological process involving numerous physiological2
factors. To accelerate the healing process, wound dressings have been used since3
ancient times [1]. Modern dressings must both provide basic protection for the wound4
site and also accelerate the healing process [2, 3]. Various materials have been reported5
in the literature in attempts to achieve the latter, including foams, films, hydrocolloids,6
hydrogels, and hydrofibers (inter alia) [4-8]. Electrospun fibers have attracted much7
attention in this regard, and have a number of potential advantages as wound dressing8
materials.9
Electrospinning is a simple and effective method for producing fibers with10
diameters ranging from tens of nanometers to micrometers. The materials fabricated by11
this route not only have high porosity and surface area-to-volume ratios (with the12
possibilities of tuning both), but also resemble the morphological structure of the extra-13
cellular matrix (ECM) and generally have good biocompatibility [9-11]. As a result of14
these characteristics, they have hemostatic properties, and are absorbable and semi-15
permeable, giving great promise as wound dressing materials [12]. Furthermore,16
various functional ingredients can easily be incorporated into fibers via electrospinning17
[1]. This could yield multi-functional wound healing materials.18
To date, a number of polymers have been used to fabricate electrospun wound19
dressings, including gelatin, collagen, chitosan, poly(vinyl alcohol), poly(ε-20
caprolactone) (PCL), and poly(L-lactic acid) [3, 13-16]. Of particular interest is poly(l-21
lactic acid-co-ɛ-caprolactone) (PLCL), a copolymer of L-lactic acid and ε-caprolactone 22
which has outstanding mechanical properties, biocompatibility and degradability [17].23
The use of electrospun PLCL scaffolds has been widely investigated in tissue24
regeneration [18, 19]), but has attracted much less attention in the context of wound25
dressing materials.26
Beyond these simple systems, more complex stimuli-responsive polymers have27
been shown to have great promise in biomaterials, drug delivery systems and sensors28
[20-25]. They exhibit a change in configuration, dimensions, or physicochemical29
properties after exposure to an external stimulus, such as changes in temperature, pH,30
3electromagnetic field, or light [26-28]. Poly(N-isopropylacrylamide) (PNIPAAm) is a1
typical temperature-sensitive polymer. In aqueous solution it undergoes a sharp phase2
transition from linear to globular at a lower critical solution temperature (LCST) of 323
ºC [29-31]. When the temperature is raised through the LCST, PNIPAAm changes from4
being hydrophilic to hydrophobic [32-34]. It has been intensively studied for potential5
applications in biomedicine [35-38], and has also been electrospun successfully [33, 39,6
40]. Moreover, it has been found that thermosensitive materials like PNIPAAm can7
effectively control cell adhesion and detachment through variation in the temperature8
[41]. The strength of interactions between the polymer and cells is generally increased9
above the LCST, and thus if a polymer has an LCST a little below the human body10
temperature a low-temperature treatment can be applied to reduce attractions between11
the polymer and cells [42]. This could in turn reduce secondary injuries caused when a12
dressing is removed from a wound.13
Several researchers have reported thermosensitive wound dressings generated from14
PNIPAAm [43-45]. For example, systems based on PNIPAAm, polyurethane and15
chitosan have been proven to exhibit good biocompatibility, antibacterial ability and16
water vapor transmission [46]. In other work, Yang et al. found that polymer17
membranes synthesized from PNIPAAm, methyl methacrylate, and 2-hydroxyethyl18
methacrylate have low cytotoxicity, promising thermosensitivity and good cell19
detachment properties [43], with 90% of L929 cells being detached at 15 ºC. However,20
most of the reported thermosensitive dressings based on PNIPAAm were not fabricated21
by electrospinning, and we hypothesized that preparing similar systems in the form of22
electrospun fibers would result in a number of advantageous properties.23
The work described in this paper forms part of a programme of research aiming to24
prepare wound dressings from electrospun fibers. We focus on blend materials25
containing both a thermosensitive polymer and a second material to provide the26
required mechanical properties. Previously, we have explored electrospun fibers based27
on poly(di(ethylene glycol) methyl ether methacrylate) and PLCL, and found these to28
be promising in reducing secondary injuries [47]. However, there remains the need to29
systematically explore a wide range of polymers in order to identify the optimum30
4system for use in the clinic, and this work builds on our previous results to investigate1
an alternative thermosensitive polymer. Here, we thus blended PNIPAAm and PLCL to2
fabricate composite fibers via electrospinning. Ciprofloxacin (CIF), a fluoroquinolone3
antibiotic, was also incorporated to provide antibacterial properties. In vitro and in vivo4
investigations of the CIF-loaded PNIPAAm/PLCL wound dressing materials were5
undertaken. This is the first time PNIPAAm/PLCL fibers have been electrospun and6
explored for their potential in wound dressings.7
8
2. Experimental details9
2.1 Materials10
N-isopropylacrylamide (NIPAAm) was purchased from Japan TCI (Japan).11
Ciprofloxacin (CIF, purity ≥ 98%), phosphate-buffered saline (PBS), sodium azide, 12
penicillin, trypsin and thiazolyl blue (MTT) were procured from Sigma-Aldrich Ltd.13
(USA). Azobisisobutyronitrile (AIBN), anhydrous ethanol, acetone, formaldehyde and14
n-hexane were obtained from the Sinopharm Chemical Reagent Co., Ltd (China).15
Poly(l-lactic acid-co-ε-caprolactone) (PLCL, 50:50; Mw = 34.5×104g/mol) was16
provided by Nara Medical University (Japan). 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP,17
99.5%) came from the Aladdin Industrial Corporation (China). L929 cells were18
provided by the Institute of Biochemistry and Cell Biology (Chinese Academy of19
Sciences, China). Dimethyl sulfoxide (DMSO) and DMEM culture medium were20
sourced from Jinuo Biological Medicine Technology Ltd. (China). All other chemicals21
used were analytical grade, and water was doubly distilled before use.22
23
2.2 Polymerization of NIPAAm24
PNIPAAm was prepared by free-radical polymerization in accordance with previous25
work [48]. NIPAAm (5.0 g) and AIBN (25.0 mg) were dissolved in anhydrous ethanol26
(10 mL) and heated at 70 ºC under a positive pressure of N2. After 7 h, the resultant27
polymer was precipitated in n-hexane. This crude product was re-precipitated from 5028
mL of acetone into 200 mL of n-hexane three times, and the purified material dried for29
3 days in a vacuum oven (DZF-6050, Shanghai Laboratory Instrument Work Co. Ltd.,30
5China). Successful polymerization was verified by 1H nuclear magnetic resonance (AV-1
400 instrument, Bruker, Germany) and IR spectroscopy (Nicolet-Nexus 670 FTIR2
spectrometer, Nicolet Instrument Corporation, USA). Molecular weights (Mw and Mn)3
and molecular weight distributions were determined by gel permeation chromatography4
(GPC) measurements on a Waters LS measurement system (Waters, USA) with5
tetrahydrofuran (THF) as the solvent. The flow rate was 1.0 mL/min, and the column6
temperature was 35 ºC. The molecular weight distribution was calibrated with standard7
polystyrene samples.8
9
2.3 Preparation of electrospinning solutions10
PNIPAAm and PLCL were co-dissolved in HFIP under magnetic stirring for 15 h at11
room temperature to obtain clear and homogenous solutions. The component ratios of12
PNIPAAm to PLCL were 1:1 or 1:2 (w/w), and the total concentration of polymer was13
10 % (w/v). Solutions of PLCL alone (10 % w/v in HFIP) were also prepared as controls.14
The antibiotic CIF was added into the solutions at a drug to polymer ratio of 1:10 (w/w)15
[49]. Full details of the solutions prepared are listed in Table 1.16
17
Table 1. Details of the electrospinning solutions prepared. The total polymer18
concentration was 10 % w/v in all cases.19
Sample Solution contents
PNIPAAm to PLCL ratio
(w/w)
Drug concentration
(% w/v)
S1 PNIPAAm/ PLCL 1:1 ---
S2 PNIPAAm/ PLCL 1:2 ---
S3 PLCL --- ---
S4 PNIPAAm/ PLCL /CIF 1:1 1.0
S5 PNIPAAm/ PLCL /CIF 1:2 1.0
S6 PLCL /CIF --- 1.0
20
2.4 Electrospinning21
6Each of the electrospinning solutions was placed into a 5 mL plastic syringe fitted with1
a stainless steel needle (internal diameter 0.5 mm), and the syringe mounted on a2
syringe pump (KDS100, Cole-Parmer, USA). The solution was expelled from the3
syringe at a rate of 1.0 mL/h and a high voltage power supply (ZGF-2000, Shanghai4
Sute Electrical Co. Ltd., China) used to apply a voltage of 14 kV between the needle5
and a grounded collector (a flat piece of aluminum foil of 12 x 12 cm in size). The6
distance between the needle tip and the grounded collector was fixed at 10 cm. The7
relative humidity was ca. 40 %, and the temperature 25 ºC. After electrospinning for 58
h, the products were stored in a vacuum oven at room temperature for 24 h to remove9
residual solvent.10
11
2.5 Morphological observations12
The morphology of the fibers was observed by scanning electron microscopy (SEM;13
JSM-5600 LV microscope, JEOL, Tokyo, Japan). Samples were first gold sputter-14
coated for 60s under argon to make them electrically conductive. They were then15
imaged using SEM at a voltage of 10 kV. The average fiber diameter for each sample16
was calculated by measuring approximately 100 fibers in SEM images, using the17
ImageJ software (National Institutes of Health, USA) [50].18
19
2.6 Further characterization20
Characterization was undertaken following the best-practice reported in the literature21
[1, 3, 10, 17, 18, 50]. X-ray diffraction (XRD) was performed on a D/Max-BR22
diffractometer (Rigaku, Japan). The instrument is supplied with Cu Kα radiation 23
(1.5418 Å; 40 kV and 30 mA), and patterns were collected over the 2θ range 5-60º.  24
Fourier transform infrared (FTIR) spectra were obtained using a Nicolet-Nexus25
670 FTIR spectrometer (Nicolet Instrument Corporation, USA) over the range 500-26
4000 cm−1, at a resolution of 2 cm−1.27
The water contact angle (CA) was determined on a contact angle analyzer (DSA28
30, Krüss GmbH, Germany) in air. A water droplet (ca. 5 µL) was placed onto the29
surface of the fibers and the CA recorded. The measurement temperature was varied30
7from 20 ºC to 45 ºC using a heating platform (XMTD-204, JTHF Company, China).1
Five measurements were recorded for each sample, and the results are reported as mean2
± S.D.3
4
2.7 In vitro drug release5
Drug release experiments were conducted at 37 ºC and 110 rpm in a thermostatic6
shaking incubator (Jintan Instrument Co. Ltd., China). 0.1 g of each of the CIF-loaded7
fiber samples was immersed in 30 mL of phosphate buffer solution (PBS, pH 7.4). At8
predetermined time points, 1 mL of the test medium was withdrawn and an equal9
amount of fresh preheated PBS added to maintain the total solution volume [47, 48].10
The concentration of CIF was measured using a UV-vis spectrometer (UV-1800, SHJH11
Company, China) at a wavelength of 269 nm. All the release studies were performed in12
triplicate, and the results are given as mean ± S.D.13
14
2.8 Antibacterial activity15
In this assessment, 105 colony forming units (CFUs) of E. coli (Gram-negative; ATCC16
25922) and S. aureus (Gram-positive; ATCC 27853) were selected as representative17
microorganisms, and cultured in Lauria Broth (LB). First, the minimum inhibitory18
concentrations (MIC) of CIF against the two microorganisms were quantified using the19
broth method, following protocols detailed in the literature [51]. Bacteria were cultured20
in the appropriate medium supplemented with CIF at a concentration of 200, 100, 50,21
25, 12.5, 6.25, 3.125, 1.562, 0.78 or 0 μg/mL. After culture for 24 hours, the MIC of 22
CIF could be determined via observation of the bacterial growth.23
Antibacterial activities of the fibers were studied using the disc diffusion method24
of the US Clinical and Laboratory Standards Institute (CLSI) [49]. The fiber samples25
were cut into circular discs 2 cm in diameter and sterilized by 75 % alcohol steam for26
24 h. 100 μL of the bacterial suspension being studied was added to an agar plate in a 27
Petri dish (of diameter 9.8 cm), and then the fiber discs were placed on the surface of28
the agar plate. All the dishes were incubated at 37 ºC for 12 h, after which the inhibition29
zones were then measured. Zones are reported as the diameter of the inhibition circle30
8observed. Six replicate experiments were performed, and the results are reported as1
mean ± S.D.2
3
2.9 MTT assays4
Fibers were first electrospun directly onto cover slips following protocols in the5
literature [17]. 20 cover slips were placed onto the collector plate and 4 mL of spinning6
solution was dispensed onto them. The fiber-covered slips were placed into the wells7
of 24-well plates, with untreated cover slips used as a negative control. Prior to cell8
culture experiments, the plates were sterilized with alcohol steam for 24 h. Complete9
DMEM medium was prepared by supplementing DMEM with 10 % v/v fetal bovine10
serum and 1% (v/v) of a pre-made penicillin (0.08 mg/ml) / streptomycin (0.1 mg/ml)11
solution.12
400 μL of dissociated L929 fibroblasts (5.0 × 103 cells/mL) in complete DMEM13
was added to each well, and the plates placed in an incubator (37 ºC, 5 % CO2). During14
the incubation period, the culture medium was replaced on a daily basis. At15
predetermined time points (after 1, 3, or 5 days of culture), the medium in each well16
was replaced by 360 μL of fresh DMEM and 40 μL of an MTT solution (5 mg/mL 17
thiazolyl blue in PBS). After incubation for 5 hours, the solution in each well was18
replaced with 400 μL DMSO and the plates shaken for 30 min. The solution in each 19
well was transferred to a 96-well plate and the absorbance measured at a wavelength of20
570 nm, using a microplate reader (Multiskan FC, Thermo Scientific Instrument Co.21
Ltd., China). Three independent MTT assays were carried out, with 5 replicates per22
assay.23
24
2.10 In vivo experiments25
Animal experiments were performed under certificate SYZK 2014-0022 issued by the26
Shanghai Science and Technology Committee, in full accordance with their rules and27
regulations. Male SD (Sprague Dawley) rats from SLAC Laboratory Animals Inc.28
(China) weighing from 230-260 g were used as animal models. The animals were29
anesthetized with an intraperitoneal injection of pentobarbitone sodium (50 mg/kg) and30
9then an open excision type wound of ca. 3 cm × 3 cm (900 mm2) was created to the1
depth of loose subcutaneous tissue on their upper backs. S4, S5 or S6 fiber mats (3 cm2
× 3 cm (900 mm2)) which had been pre-sterilized by alcohol steam for 24 h were used3
to cover the skin wounds. A pure cotton commercial gauze was placed on top of the4
mats, and the gauze edge sutured to the skin around the wound area. This is in5
accordance with a previously reported protocol [52]. Commercial gauzes (Shanghai6
Yinjing Meidical Supplies Company Ltd., China) soaked with a 0.9 % w/v CIF solution7
were used as a control group. There were seven rats in each group.8
9
2.11 Macroscopic observation of wound healing10
After recovery from anaesthesia, the rats were housed individually in disinfected cages11
at a temperature of 25 ± 2 ºC. The dressings in all the groups were replaced every three12
days. Before replacement, the fibers and gauzes on the wounds were treated with sterile13
saline at 25 ºC. The appearance of the wound was photographed at selected times post-14
operation and the area of unhealed wound measured from the images using the15
Photoshop software (Adobe, USA). The relative wound area was determined as follows:16
Relative wound area = St/S0×100%17
where St and S0 are the wound areas on the specified day and operation day, respectively.18
19
2.12 Histological and immunohistochemical examinations20
21 days after operation, three rats from each group were sacrificed using a large dose21
of anesthetic. The wound sections were excised, collected and cut into small sections22
(ca. 4 µm). The sections were fixed with 10 % v/v formaldehyde in water, rinsed in23
water, and placed in a transparent block of melted paraffin. Care was taken to ensure24
that the samples were completely immersed in the block, after which the sections were25
fixed on a slicer for hematoxylin-eosin (HE) staining. For the latter, the sections were26
washed with distilled water, stained with hematoxylin, rinsed under running tap water,27
and differentiated with 0.3% acid alcohol. They were then again rinsed under running28
tap water, before being stained with eosin for 2 min, dried, cleaned and mounted. HE-29
stained sections were observed with the aid of a light microscope (Nikon Eclipse E400,30
10
Japan).1
2
2.13 Statistical analysis3
Statistics analysis was performed using Origin v8.5 (Origin Lab Inc., USA). All values4
were determined at least in triplicate and are expressed as mean ± standard deviation5
(SD). Statistical differences were determined by one-way ANOVA, with differences at6
p < 0.05 considered significant.7
8
9
3. Results and discussion10
3.1 Synthesis of PNIPAAm11
The successful synthesis of PNIPAAm was verified by 1H NMR (Fig. S1). The NMR12
spectrum of the polymer shows no signals attributable to methylene protons (see Fig.13
S1(a)), whereas in that of the monomer (NIPAAm, Fig. S1(b)) vinyl peaks at ca. 5.514
and 6.2 ppm can clearly be seen. Instead, PNIPAAm shows peaks at around 1.4 and 2.015
ppm, typical of saturated systems and agreeing with a previous study [53], indicating16
the successful formation of the polymer. Similar conclusions can be drawn from FTIR17
spectra (Fig. S2). NIPAAm shows a sharp band at 1621 cm-1 (C=C stretching), which18
has disappeared in the spectrum of PNIPAAm. The molecular weights (Mw and Mn)19
and molecular weight distribution (PDI) determined by GPC were 11479 Da, 10380 Da,20
and 1.12, respectively.21
22
3.2 Fiber morphology23
SEM images and the calculated diameter distributions for all the electrospun materials24
are shown in Fig. 1. It is immediately obvious from the images that fiber formation was25
successful. Considering the drug-free fibers, the pure PLCL S3 fibers have the largest26
diameters (915 ± 116 nm). The diameters of S1 (PNIPAAm : PLCL 1:1; 898 ± 155 nm)27
are a little smaller, but much larger than S2 (PNIPAAm : PLCL 1:2; 699 ± 110 nm).28
Hence, there is no clear relationship between the content of PNIPAAm and fiber29
diameter. While the S1 – S3 fibers have generally smooth and cylindrical morphologies,30
11
the CIF-loaded fibers are less uniform. Some beads can be seen on the surface of the1
latter, which could result from an increase in viscosity with the addition of CIF. It has2
been reported that increased solution viscosity can improve electrospinnability and aid3
the formation of smooth fibers. However, higher viscosities can also lead to the4
formation of beaded fibers [54, 55]. The diameters of the fibers loaded with CIF (S4-5
S6) are rather narrow, being smaller than the pure polymer materials in all cases. In the6
most extreme example, the average diameter of S6 (PLCL/CIF) is 620 ± 127 nm as7
compared to 915 ± 116 nm for the analogous drug-free system S3. This could be caused8
by an increase in conductivity following the addition of CIF, which is known to9
facilitate elongation of the polymer jet and to generate narrower fibers [56].10
11
12
Fig. 1 SEM images and diameter distributions of the fibers produced.13
14
3.3 X-ray diffraction15
12
XRD patterns of the CIF-loaded fibers (S4, S5 and S6) can be seen in Fig. 2(a),1
along with that of pure CIF. The latter exists in a crystalline state, displaying a number2
of characteristic reflections between 5° and 50° 2θ. The fibers loaded with CIF display 3
only two broad diffuse peaks centered at around 17° and 23°, and the characteristic4
reflections of CIF cannot be seen. Therefore, CIF is dispersed in the fibers in an5
amorphous state, as is commonly seen for electrospun materials. These results are in6
full agreement with numerous studies in the literature [47, 50, 57]. As has been widely7
reported, the very rapid solvent evaporation which occurs during electrospinning does8
not allow sufficient time for the molecular organization required for the formation of a9
crystal lattice from a solution. As a result, the random arrangement of molecules in the10
electrospinning solution is propagated into the solid state, generating amorphous11
materials [58, 59]12
13
14
Fig. 2 a) XRD patterns of S4, S5, S6 and CIF; b) FTIR spectra of selected fibers, CIF15
and PNIPAAm; c) Water contact angles of S4, S5 and S6 as a function of16
temperature.; and, d) In vitro release profiles of CIF from S4, S5 and S6. For c) and17
d), data are reported as mean ± S.D. from three independent experiments18
13
1
2
3.4 FTIR spectroscopy3
Selected FITR spectra are presented in Fig. 2(b). PNIPAAm exhibits a broad band4
between around 3700 and 3100 cm-1, which comprises a superposition of H-bonded N-5
H stretches (3296 cm-1) and amide I and II combination and overtone bands [60]. Two6
characteristic peaks at 2979 cm-1 and 1635 cm-1 arise from C-H and C=O stretching7
vibrations, respectively. The distinct band at 1539 cm-1 results from C-N stretching and8
N-H bending vibrations. For the PLCL fibers (S3), two features at 2948 and 1757 cm-19
can be attributed to the stretching of -CH3 and C=O groups, respectively. The stretching10
of the C-O-C moiety leads to other two peaks at 1183 and 1093 cm-1[18]. The spectrum11
for CIF exhibits peaks at 3042 cm-1 (O-H stretching), 1626 cm-1 (C=O stretching), and12
numerous bands between 1582 and 1495 cm-1 from stretching vibrations of the benzene13
ring [47].14
Considering the PLCL/PNIPAAm-based fibers S1 and S4, both have the distinct15
peaks of PNIPAAm (3292, 2979, 1635, 1540 cm-1) and PLCL (1757 cm-1). In S4, most16
of the characteristic peaks of CIF overlap with other vibrations from the polymers17
(which form the majority of the fiber mass). However, it can be seen that the peak at18
1635 cm-1 is enhanced in S4 compared to the drug-free S1. This may be attributed to19
the presence of CIF. The FTIR spectra of the other fibers show similar features.20
21
3.5 Thermosensitive behavior22
The thermosensitive behavior of the fibers was explored in terms of contact angle, and23
the results are depicted in Fig. 2(c). The CA of S6 (PLCL/CIF fibers) remains at around24
135° regardless of temperature. This agrees with previous studies [18], indicating the25
consistent hydrophobic nature of PLCL-based materials. The inclusion of26
thermosensitive PNIPAAm into S4 and S5 causes a distinct change in contact angle27
between 20 and 45 ºC. At 20 ºC, the CA of S5 is 16.4 ± 3.5° which rises to 112.3 ± 6.21°28
at 45 ºC. For S4, the CAs at 20 ºC and 45 ºC are approximately 0º and 89.7 ± 4.3°. The29
CAs of S4 are lower than those of S5 at each temperature. This is expected to result30
14
from the greater proportion of hydrophobic PLCL in S5. The CAs increase dramatically1
at around 32°C, which is accordance with the reported LCST of PNIPAAm [29].2
When the temperature is below the LCST, the C=O and N-H groups in the3
PNIPAAm chains will interact with water molecules to form intermolecular hydrogen4
bonds [61], which makes the fibers relatively hydrophilic below 32°C. When the5
temperature is increased to above the LCST, the PNIPAAm C=O and N-H groups tend6
to form intramolecular hydrogen bonds, leading to a collapsed globular conformation.7
As a result, water molecules find it difficult to interact with the C=O and N-H groups,8
resulting in hydrophobic fibers. It has been demonstrated that varying the temperature9
of PNIPAAm can effectively control cell adhesion and detachment [41]. Therefore, the10
thermosensitive properties of PNIPAAm can be exploited to reduce secondary injuries11
arising upon the replacement of wound dressings, and hence to accelerate healing. This12
idea has been verified in several reports [43-46, 62], and it therefore seems likely that13
PLCL/PNIPAAm thermosensitive fibers could also have promise in this regard.14
15
3.6 Drug release16
Fig. 2(d) shows the in vitro release behavior of CIF from the drug-loaded fibers17
(S4，S5 and S6). A similar burst release of around 45 % in the first ca. 15 hours can be18
seen from all three materials. This is thought to result from the presence of some CIF19
at or near the surface of the fibers; this can rapidly diffuse into the release milieu20
regardless of the solubility of the polymer constituents [59]. After this initial release,21
all three materials exhibit gradual release over 210 h. During the latter, the rate of CIF22
release is fastest from S4, followed by S5 and S6.23
These different release behaviors can be explained by the fibers’ surface24
wettability. The mechanism of drug release from polymers can involve diffusion,25
erosion, or a combination of both, and the release rate from a hydrophilic carrier tends26
to be faster than that from a hydrophobic material [59, 63]. The contact angle data27
(Section 3.5) demonstrate that S4, containing the highest proportion of PNIPAAm, has28
the highest wettability of the three systems at 37 ºC, followed by S5 and S6. This29
corresponds to the trend in the release rates (S4 > S5 > S6). At the end of the release30
15
experiment, the cumulative release of CIF from S4, S5 and S6 reaches 83.1 ± 4.1 %,1
80.9 ± 3.8 % and 78.8 ± 4.3 %, respectively. Thus, more than 15 % of the incorporated2
CIF was not released, with the release extent also correlating with wettability. The3
residual CIF is believed to be encapsulated deep inside the fibers.4
These results of these in vitro release experiments demonstrate that5
PNIPAAm/PLCL composite fibers can sustain the release of CIF for more than 8 days.6
Although an in vitro experiment cannot be expected to mirror exactly what will happen7
in vivo, these results suggest that the fibers may be able to prevent wound infection for8
a number of days.9
10
3.7 Antibacterial activity11
Prior to exploring the the antibacterial properties of the fibers, the MICs of CIF were12
determined and found to be 12.5 μg/mL and 25 μg/mL against E. coli and S. aureus,13
respectively. As expected, CIF is high effective as an antibacterial agent.14
The inhibition zone diameters of all the fiber samples are presented in Table 2, with15
representative images for S1 and S4 in Fig. 3. The inhibition zones of all the CIF-loaded16
fibers (S4, S5 and S6) are similar in size, indicating roughly constant antibacterial17
activities. On the contrary, there are no obvious inhibition zones with the drug-free18
samples (S1, S2 and S3). The potential of CIF in wound dressing materials has been19
demonstrated many times in the literature [64, 65], and the drug also has a low20
frequency of spontaneous resistance [66, 67]. In our previous work developing CIF-21
loaded PLLA / poly(di(ethylene glycol) methyl ether methacrylate) (PDEGMA) blend22
fibers we noted inhibition zones of 5.28 – 5.52 cm for E. coli and 5.21 – 5.52 cm for S.23
aureus after 24 h [47].The ability to avoid infection by exogenous organisms should24
accelerate the process of wound healing, and it appears that the systems produced here25
are similarly effective to those reported previously.26
27
28
29
30
16
1
2
3
4
5
6
7
8
Table 2. Inhibition zone diameters for the fibers after 12 h of culture. Data are reported9
as mean ± S.D. from 6 independent experiments.10
11
Sample
Inhibition zones against E.
coli (cm)
Inhibition zones against S.
aureus (cm)
S1 --- ---
S2 --- ---
S3 --- ---
S4 5.21 ± 0.24 5.13 ± 0.20
S5 5.19 ± 0.11 5.17 ± 0.28
S6 5.24 ± 0.22 5.13 ± 0.16
12
13
17
1
Fig. 3 Inhibition zones of selected fiber samples. Representative images of a) S12
against E. coli; b) S4 against E.coli; c) S1 against S. aureus; d) S4 against S. aureus,3
taken from 6 replicate experiments. The diameters of Petri dishes are 9.8 cm4
5
3.8 Biocompatibility6
According to the literature fibroblast cells play significant roles in wound healing, so7
L929 cells were used to explore the biocompatibility of the fibers [68]. In our previous8
work, we explored the cytotoxicity of a 0.9% CIF solution to L929 cells, and minimal9
cell death was identified [47]. This thus means that any cell death induced by the fibers10
is not a property of the incorporated antibiotic, but rather of the fibers themselves.11
The results of MTT assays are depicted in Fig. 4. It is clear that the cells grew12
continuously from the 1st to the 5th day, both in the case of the untreated control and13
with all the fiber samples. The cell viabilities of cells exposed to the fibers are similar14
to those of the negative control group on day 1. After the 1st day, the S4 fibers (with the15
highest proportion of PNIPAAm) show the lowest cell viabilities. The viabilities are16
seen to be highest with the S6 fibers (PLCL alone, without PNIPAAm). The S617
18
viabilities were significantly greater than those of S4 on day 3 and 5 (p < 0.05). The1
numbers of cells cultured on S5 lay between these two extremes on days 3 and 5. These2
results indicate that L929 cells could proliferate on all the fiber samples (S4, S5 and3
S6), and thus all have good biocompatibility and are suitable as wound dressing4
materials. Moreover, the biocompatibility is enhanced by an increasing content of5
PLCL. This is expected to result from the greater cytocompatibility of PLCL than6
PNIPAAm; PLCL is widely known to be highly biocompatible [18, 69].7
8
Fig. 4 Cell viability after exposure to the fibers for 1, 3, or 5 days. Data are given as9
mean ± S.D. from 3 independent experiments.10
11
3.9 Macroscopic observations of wound healing12
The macroscopic wound healing effects of S4, S5 and S6 were compared with a13
commercial gauze (Shanghai Yinjing Meidical Supplies Company Ltd.) immersed in a14
0.9 % w/v CIF solution. Representative images of the wound healing process are given15
in Fig. 5. Around 3 h after the procedure, all the rats awoke and appeared healthy. The16
rats treated with the CIF-soaked gauze (Fig. 5(a)) displayed thicker scabs and larger17
19
wound areas than those treated with the fibers (Fig. 5(b), (c) and (d)), indicating a1
slower healing rate. This can be explained considering the advantages that nanofibers2
offer as wound dressing materials. The size and topography of electrospun fiber mats3
can promote cell attachment and proliferation. Moreover, they allow gas and fluid4
uptake and exchange, and can hence absorb wound exudates. The prolonged period of5
drug release observed from these systems is also expected to contribute to the healing6
performance [1, 12, 50, 58, 70, 71].7
Among the three fiber groups, the S4 and S5 mats were found to be easier to remove8
after treatment with cold saline, and they also have smaller wound areas than S6. At the9
end of the observation period (21 days), the scabs had largely healed and most of the10
wounds areas treated by S4 and S5 were filled with regenerated skin. The improved11
healing effects of S4 and S5 could be attributed to their thermosensitive properties (S612
has no such properties).13
Fig. S3 illustrates the relative wound areas of the four groups from the 5th to the14
21st day after operation. The results agree with the macroscopic observations in Fig. 5.15
After 5 days, the wound areas of all the samples were essentially the same. Subsequently,16
the different treatments lead to different rates of decline in the wound areas. After 2117
days, S4 (6.50 ± 3.14 %) and S5 (7.71 ± 3.32 %) showed lower areas than S6 (14.36 ±18
2.83 %) and the gauze group (24.81 ± 3.20 %). These results demonstrate that the CIF-19
loaded PNIPAAm/PLCL composite fibers could promote wound healing, performing20
better in vivo than a commercial gauze or the CIF-loaded PLCL fibers. The21
PNIPAAm/PLCL materials are approximately equally effective with the22
PDEGMA/PLCL systems reported previously [47]. The best performing23
PDEGMA/PLCL fiber formulation reduced the wound area to 5.7 ± 0.8 % of the24
original area, which is very close to the values determined for S4 and S6 here. Therefore,25
it appears that PNIPAAm can recapitulate the effects of PDEGMA in these wound26
dressings, suggesting that a wide range of thermoresponsive polymers can be employed27
in the development of clinical wound dressing products.28
29
20
1
Fig. 5 Representative images of skin wounds treated with selected samples for 0, 5, 142
and 21 days post-operation. The wounds were treated with (a) a commercial gauze3
soaked with 0.9% CIF solution, (b) S4, (c) S5 and (d) S6.4
5
3.10 Histological examinations6
HE staining images of the tissues treated by S4, S5, S6 and gauze are displayed in Fig.7
6, together with a section of healthy skin without any wound or treatment. Regenerated8
epidermis can be seen at the edge of the wounds in all groups, and is marked with circles9
in Fig. 6. With the group treated by the CIF-soaked gauze (Fig. 6(a)), the epidermis is10
thinner and more irregular than that with the groups treated using fiber dressings (Fig.11
6(b)-(d)). The epidermis of the S6 group (Fig. 6(d)) is more regular than that of the12
gauze group, but the wounds covered by S4 (Fig. 6(b)) and S5 (Fig. 6(c)) showed the13
best healing results. The continuity and regularity of the epidermis in these two groups14
is the closet to normal skin (Fig. 6(e)). Moreover, the basal cells of rats treated with S415
and S5 (marked by white arrows) exhibit more uniform shapes and more regular16
21
arrangements than other treatment groups. These results accord with the macroscopic1
observations of the wound healing (Section 3.9), and further demonstrate the improved2
healing effects of PNIPAAm/PLCL fibers loaded with CIF over other groups.3
4
5
Fig. 6 HE staining for the epithelialization of skin wounds treated for 21 days with (a)6
a commercial gauze soaked with 0.9% CIF solution, (b) S4, (c) S5, (d) S6 and (e)7
healthy skin where no wound has been inflicted. Scale bars represent 200 μm. 8
9
4. Conclusions10
In this study, thermosensitive poly(N-isopropylacrylamide) (PNIPAAm) was blended11
with (poly(l-lactic acid-co-ɛ-caprolactone)) (PLCL) and processed into fibers by 12
electrospinning. The antibiotic ciprofloxacin (CIF) was also incorporated into the13
composite fibers. The fibers show generally smooth and cylindrical morphologies, and14
the addition of CIF was found to reduce the diameters of the fibers compared to15
analogous systems made with the polymer blend alone. XRD analysis indicated that16
CIF was dispersed in the fibers in an amorphous state. The water contact angle of the17
fiber mats is highly dependent on the temperature, with the wettability of the18
PNIPAAm/PLCL fibers declining abruptly at around 32 ºC. In vitro drug release19
experiments demonstrate that CIF could be gradually released from the fibers over 20020
h. The CIF-loaded composite fibers show good antibacterial activity against E. coli and21
22
S. Aureus. They also exhibit promising biocompatibility and can promote the1
proliferation of L929 fibroblasts. In vivo wound healing observations and histological2
examinations showed that PNIPAAm/PLCL fibers loaded with CIF were able to3
accelerate healing, and the blend fibers perform better than those containing only PLCL4
and CIF. These results thus demonstrate the potential of PNIPAAm/PLCL fibers loaded5
with CIF as potent wound dressing materials.6
7
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